Cargando…
Immunologic phenotype of patients with long-COVID syndrome of 1-year duration
BACKGROUND: The pathophysiology of long-COVID remains unknown, and information is particularly limited for symptoms of very long duration. We aimed to assess the serological, T-cell immune responses and ANA titers of patients with long-COVID-19 syndrome of 1-year duration. METHODS: Prospective, long...
Autores principales: | García-Abellán, Javier, Fernández, Marta, Padilla, Sergio, García, José Alberto, Agulló, Vanesa, Lozano, Valle, Ena, Nuria, García-Sánchez, Lidia, Gutiérrez, Félix, Masiá, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451924/ https://www.ncbi.nlm.nih.gov/pubmed/36090973 http://dx.doi.org/10.3389/fimmu.2022.920627 |
Ejemplares similares
-
Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade
por: Masiá, Mar, et al.
Publicado: (2022) -
Preemptive interleukin-6 blockade in patients with COVID-19
por: Guillén, Lucía, et al.
Publicado: (2020) -
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study
por: Masiá, Mar, et al.
Publicado: (2020) -
Antibody Response to SARS-CoV-2 is Associated with Long-term Clinical Outcome in Patients with COVID-19: a Longitudinal Study
por: García-Abellán, Javier, et al.
Publicado: (2021) -
Durable antibody response one year after hospitalization for COVID-19: A longitudinal cohort study
por: Masiá, Mar, et al.
Publicado: (2021)